European Journal of Heart Failure

FEBRUARY 20, 2024

Diagrammatic illustration of trends of incident heart failure diagnosis and diagnostic testing in the US from 2016 to 2019 stratified by inpatient and outpatient setting. We also found increasing rates of inpatient HF diagnoses, indicating lost opportunities for earlier treatment initiation and better outcomes.

Heart Failure 40

Heart Failure Inpatient Outpatient Outcomes 40

Circulation

NOVEMBER 11, 2024

This study evaluates the outcomes in patients admitted for HF with and without hyperkalemia.Methods:We used the Nationwide Readmissions Database (NRD) from 2016-2019, extracting adult patients with a primary diagnosis of HF who were admitted between January and November of each year. vs. 2.5%, p < 0.001). 2], p<0.001).Conclusion:Hyperkalemia

Inpatient 40

Inpatient Heart Failure Outcomes Cardiac Arrest 40

Circulation

NOVEMBER 11, 2024

Background:Tricuspid regurgitation (TR) is a common occurrence in patients with heart failure (HF), and its role in disease progression has gained attention in recent years. While TR can worsen the clinical outcomes in HF patients, its impact on gender, racial and socioeconomic factors remains largely unexplored. and I07.1.

Heart Failure 40

Heart Failure Tricuspid Outcomes Medicare 40

Circulation: Heart Failure

OCTOBER 27, 2023

Circulation: Heart Failure, Volume 16, Issue 11 , Page e010524, November 1, 2023. The role of obesity in RV dysfunction and adverse outcomes is unclear.METHODS:We examined patients undergoing right heart catheterization between 2005 and 2016 in a hospital-based cohort. P<0.001). Over median of 7.3

Obesity 40

Obesity Outcomes Heart Failure Pulmonary 40

Journal of the American Heart Association

MARCH 27, 2025

years]) admitted to the China Chest Pain Center Database between 2016 and 2021. The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models.

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Journal of Cardiovascular Electrophysiology

MARCH 11, 2025

Despite guideline recommendations for complete device removal, disparities in healthcare access and resource availability between urban and rural settings may influence patient outcomes. This study aims to evaluate ruralurban disparities in the management and outcomes of patients hospitalized with CIED infections. in rural hospitals.

Hospital 40

Hospital Outcomes Atrial Fibrillation Embolism 40

Stroke Journal

FEBRUARY 1, 2024

Annual follow-up interviews were conducted from inception until 2016 to determine outcomes of interest. Hospital records were reviewed and incident MACE, defined as the composite of incident stroke, myocardial infarction, or heart failure, was adjudicated using standard criteria. P<0.001), physical activity (82.1

Myocardial Infarction 40

Myocardial Infarction Blood Pressure Outcomes Diet 40

Circulation

NOVEMBER 11, 2024

Understanding the association with acute myocarditis (AMC) is crucial for preemptive management strategies and improving patient outcomes.Methods:We identified and compared adults (>18 years) with SID vs. non-SID patients hospitalized with AMC using the National In-patient sample database from 2016-2020.

Hospital 40

Hospital Outcomes Cardiac Arrest Heart Failure 40

Circulation: Cardiovascular Interventions

APRIL 7, 2025

However, the association between the extent of cardiac damage at the time of AVR and health care costs and resource utilization has never been described.METHODS:The Optum de-identified Market Clarity database was used to identify patients with aortic stenosis treated with AVR between 2016 and 2022. in stage 0, 17.1% in stage 1, 37.3%

Aortic valve 40

Aortic valve Aortic Heart Failure Quality of Life 40

Circulation

NOVEMBER 11, 2024

Socioeconomic status (SES) is a well-validated risk factor for poor outcomes among patients with heart failure, but its influence on adverse events in patients post-LVAD is poorly understood and may be overestimated. Further studies are necessary to evaluate if DCI impacts other adverse outcomes post LVAD.

BMI 40

BMI Outcomes Laboratory Heart Failure 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 13, 2024

Abstract Introduction Clinical outcomes of long-term ventricular septal pacing (VSP) without His-Purkinje capture remain unknown. This study evaluated the differences in clinical outcomes between conduction system pacing (CSP), VSP, and right ventricular pacing (RVP). Results Among 1016 patients (age 73.9 ± 11.2

Bradycardia 40

Bradycardia Physiology Pacemaker Heart Failure 40

Circulation

NOVEMBER 11, 2024

We collected demographic, pre-procedural, procedural, and outcome-related variables. The multivariate analysis also revealed that age less than a year, HCM compared to DCM, history of heart failure, pre-procedural inotropic support, and non-elective procedure were associated with increased rate of MAE. were females.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

DAIC

MARCH 1, 2024

In a new study published in JACC: Heart Failure , maternal loss of a partner or child shortly before or during pregnancy was found to be associated with increased risk of heart failure up to middle-age in the child. According to the World Heart Federation, more than 64 million people worldwide have heart failure.

Heart Failure 105

Heart Failure Public Health Cardiovascular Disease Research 105

Journal of the American Heart Association

DECEMBER 14, 2024

Journal of the American Heart Association, Volume 13, Issue 24 , December 17, 2024. The main outcome was the composite of allcause mortality and first HF hospitalization. EAT volume exhibited a strong unadjusted association with the composite outcome (hazard ratio per 1 mL/m2[HR], 1.57 [95% CI, 1.401.76],P<0.001).

Preserved Ejection Fraction 58

Preserved Ejection Fraction Heart Failure Hospital Outcomes 58

Cardiology Update

MARCH 17, 2024

Data were prospectively gathered from individuals aged 1 to under 18 years participating in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis long-term registry spanning from June 2014 to December 2016. Outcomes: Over a median follow-up of 12.5 months (IQR: 11.3–15.3),

Cardiomyopathy 119

Cardiomyopathy Pediatrics Article Research 119

DAIC

JULY 24, 2024

The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. 1 Approximately 33 million patients worldwide are living with AFib.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

Cardiometabolic Health Congress

JULY 25, 2023

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] Is the obesity paradox a real phenomenon?

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCardiomyopathy (CM) is a diverse pathology defined by both structural and functional changes in the heart. The National Inpatient Sample (NIS) database from 2016‐2019 for patients with a principal diagnosis of AIS using the ICD‐10 code I63 was queried. AIS patients with CM and HF were compared to those without.

Heart Failure 40

Heart Failure Cardiomyopathy Inpatient Stroke 40

Frontiers in Cardiovascular Medicine

FEBRUARY 14, 2024

Methods Using the Korean National Health Insurance Service database, we included patients aged ≥75 years with new-onset AF from January 2009 to December 2016 ( n  = 41,315). Group 4 was associated with the lowest risk of all-cause death (aHR: 0.680, 95% CI: 0.613–0.754) and the composite outcome (aHR: 0.708, 95% CI: 0.649–0.772).

Atrial Fibrillation 72

Atrial Fibrillation Stroke Strokes Heart Failure 72

Open Heart

OCTOBER 7, 2024

We reviewed the characteristics and in-hospital outcomes and developed a novel risk score for TC. Methods Using the National Inpatient Sample data from 2016 to 2020, we identified adult patients (≥18 years) with acute coronary syndrome (ACS) and TC. to 7.09), p<0.001) and chronic heart failure (OR 1.60 (95% CI 1.54

Inpatient 52

Inpatient Coronary Artery Bypass Graft Cardiomyopathy Cardiogenic Shock 52

Heart BMJ

JUNE 25, 2024

The primary outcome was the first occurrence of major cardiovascular events defined as a composite of hospitalisation for acute coronary syndrome (non-fatal myocardial infarction and unstable angina), fatal myocardial infarction, non-fatal and fatal stroke, sudden death and heart failure. years (interquartile interval 4.4–4.9).

Cardiovascular Disease 59

Cardiovascular Disease Myocardial Infarction Pharmacology Angina 59

Circulation

NOVEMBER 11, 2024

Background:Tricuspid regurgitation (TR) is a common occurrence in patients with heart failure (HF), and its role in disease progression has gained attention in recent years. While TR can worsen the clinical outcomes in HF patients, its impact on gender, racial and socioeconomic factors remains largely unexplored.

Heart Failure 40

Heart Failure Hospital Tricuspid Medicaid 40

European Journal of Heart Failure

NOVEMBER 3, 2023

Among 475 patients with cardiac sarcoidosis, 119 (25.1%) were isolated cardiac sarcoidosis (iCS) based on the 2016 Japanese Circulation Society criteria. iCS was diagnosed according to the 2016 Japanese Circulation Society (JCS) guidelines. months, 141 primary outcomes (29.7%) occurred. During a median follow-up of 42.3

Heart Failure 40

Heart Failure Atrial Fibrillation Tachycardia Arrhythmia 40

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2024

BackgroundWomen with heart failure with reduced ejection fraction (HFrEF) often experience worse clinical outcomes compared to men, including higher rates of mortality, hospitalization, and congestion. Ischemic cardiomyopathy (ICM) was less common as a cause of heart failure (HF) in women than in men (32% vs. 57.7%, p=0.001).

Heart Failure 40

Heart Failure Outcomes Hospital Tachycardia 40

DAIC

OCTOBER 2, 2024

vs 24% showed enhanced exercise capacity and 84% vs 8% demonstrated a substantial response in cardiac biomarkers (for all p aficamten achieved one or more clinically relevant outcomes, 62% achieved at least three outcomes and 23% achieved all four outcomes. CVrg: Heart Failure 2020-2029, p 44; Maron et al.

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Biomarkers Heart Failure 40

Journal of the American Heart Association

JANUARY 16, 2025

BackgroundThe study investigates the prognostic impact of sex and sexrelated differences in patients hospitalized with heart failure with mildly reduced ejection fraction (HFmrEF). Female patients were compared with male patients with regard to the primary end point of allcause mortality at 30 months (median followup).

Heart Failure 45

Heart Failure Hospital Cardiomyopathy Outcomes 45

Dr. S. Venkatesan MD

FEBRUARY 20, 2024

SCD is the leading cause of mortality in heart failure. N Engl J Med 2016; 375:1221-1230) Why ICD doesn’t work well in NDCM ? Bardy GH, Lee KL, Mark DB, Poole JE, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. 2016 Sep 29;375(13):1221-30. N Engl J Med. 2005 Jan 20;352(3):225-37.

Heart Failure 52

Heart Failure Defibrillator Sudden Cardiac Death Cardiomyopathy 52

European Journal of Heart Failure

DECEMBER 7, 2023

Abstract Background and Aims Patients who experience hospitalizations due to heart failure (HF) face a significant risk of readmission and mortality. Methods We studied all adults admitted for a first HF hospitalization from 2016 to 2020 in France's Grand Est region. Results Among 67 476 admitted patients (mean age 80.3 ± 11.3 years,

Heart Failure 40

Heart Failure Hospital Outpatient Article 40

Circulation

JANUARY 23, 2024

BACKGROUND:Guideline-directed medical therapies (GDMTs) are the mainstay of treatment for heart failure with reduced ejection fraction (HFrEF), but they are underused. The primary outcome was the use of optimal GDMT within 12 months of HFrEF diagnosis.

Heart Failure 45

Heart Failure Medicare Circulation Outcomes 45

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Dr. Smith's ECG Blog

APRIL 8, 2015

Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. History of Cardiovascular disease (all studies): Especially any history of heart failure or structural cardiac disease, including valvular 4. Abnormal ECG – looks for cardiac syncope. Syncope with Exertion (EGSYS) 7.

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

Dr. Malcolm Kendrick

OCTOBER 30, 2024

(2022-25) Swiss Reinsurance Company: £645K China Kadoorie Biobank (2002-ongoing) AstraZeneca: $300K Bayer AG: £300K GlaxoSmithKline: £3.6M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M

Cholesterol 145

Cholesterol Article Research Diet 145